Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19167733 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Thalidomide;   Drug: leuprolide acetate;   Drug: goserelin;   Other: Placebo

Indicates status has not been verified in more than two years